Sphera Funds Management as of March 31, 2014
Portfolio Holdings for Sphera Funds Management
Sphera Funds Management holds 111 positions in its portfolio as reported in the March 2014 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Novartis (NVS) | 10.3 | $46M | 535k | 85.02 | |
| GlaxoSmithKline | 7.9 | $35M | 650k | 53.43 | |
| Sanofi-Aventis SA (SNY) | 7.6 | $33M | 320k | 104.31 | |
| Merck & Co (MRK) | 6.8 | $30M | 530k | 56.77 | |
| Pfizer (PFE) | 6.2 | $27M | 855k | 32.12 | |
| Johnson & Johnson (JNJ) | 5.0 | $22M | 224k | 98.23 | |
| Eli Lilly & Co. (LLY) | 4.0 | $18M | 300k | 58.86 | |
| Financial Select Sector SPDR (XLF) | 3.5 | $15M | 681k | 22.34 | |
| Health Care SPDR (XLV) | 2.1 | $9.3M | 159k | 58.49 | |
| Amgen | 2.0 | $8.6M | 70k | 123.34 | |
| Gilead Sciences (GILD) | 1.5 | $6.7M | 94k | 70.86 | |
| Seattle Genetics | 1.3 | $5.8M | 128k | 45.56 | |
| Perrigo Company (PRGO) | 1.3 | $5.6M | 36k | 154.66 | |
| Biogen Idec (BIIB) | 1.2 | $5.2M | 17k | 305.88 | |
| United Therapeutics Corporation (UTHR) | 1.1 | $4.7M | 50k | 94.04 | |
| TJX Companies (TJX) | 1.0 | $4.5M | 75k | 60.65 | |
| Incyte Corporation (INCY) | 1.0 | $4.4M | 83k | 53.52 | |
| Colgate-Palmolive Company (CL) | 0.9 | $4.1M | 63k | 64.87 | |
| Teva Pharmaceutical Inds Ltd option | 0.9 | $4.0M | 3.0k | 1321.00 | |
| Nike (NKE) | 0.8 | $3.7M | 50k | 73.85 | |
| Spdr S&p Oil & Gas Exp & Pr put | 0.8 | $3.6M | 2.8k | 1292.86 | |
| Energy Select Sector SPDR (XLE) | 0.8 | $3.6M | 40k | 89.05 | |
| Broadcom Corporation | 0.8 | $3.5M | 113k | 31.48 | |
| Spdr Euro Stoxx 50 Etf (FEZ) | 0.8 | $3.5M | 83k | 42.66 | |
| Orbotech Ltd Com Stk | 0.8 | $3.4M | 223k | 15.39 | |
| CSX Corporation (CSX) | 0.8 | $3.4M | 117k | 28.97 | |
| Walgreen Company | 0.8 | $3.4M | 52k | 66.02 | |
| Teva Pharmaceutical Industries (TEVA) | 0.7 | $3.3M | 62k | 52.83 | |
| 0.7 | $3.2M | 2.9k | 1114.53 | ||
| Precision Castparts | 0.7 | $3.2M | 13k | 252.80 | |
| Industrial SPDR (XLI) | 0.7 | $2.9M | 55k | 52.32 | |
| Clovis Oncology | 0.6 | $2.8M | 40k | 69.28 | |
| CVS Caremark Corporation (CVS) | 0.6 | $2.7M | 36k | 74.87 | |
| priceline.com Incorporated | 0.6 | $2.7M | 2.2k | 1191.79 | |
| Regado Biosciences | 0.6 | $2.5M | 200k | 12.52 | |
| Redhill Biopharma Ltd cmn | 0.6 | $2.4M | 1.7M | 1.42 | |
| Aquinox Pharmaceuticals | 0.6 | $2.4M | 190k | 12.73 | |
| Biomarin Pharmaceutical Inc note 1.875% 4/2 | 0.5 | $2.4M | 35k | 68.20 | |
| Aerie Pharmaceuticals | 0.5 | $2.4M | 113k | 21.19 | |
| NPS Pharmaceuticals | 0.5 | $2.3M | 78k | 29.94 | |
| Las Vegas Sands (LVS) | 0.5 | $2.2M | 28k | 80.76 | |
| Oncothyreon | 0.5 | $2.2M | 738k | 2.99 | |
| Rexahn Pharmaceuticals | 0.5 | $2.2M | 2.0M | 1.08 | |
| Prothena (PRTA) | 0.5 | $2.1M | 55k | 38.31 | |
| NOVA MEASURING Instruments L (NVMI) | 0.5 | $2.0M | 181k | 11.20 | |
| Silicom (SILC) | 0.5 | $2.0M | 32k | 62.05 | |
| Trevena | 0.5 | $2.0M | 250k | 7.86 | |
| Galmed Pharmaceuticals | 0.4 | $1.9M | 170k | 11.47 | |
| Charles Schwab Corporation (SCHW) | 0.4 | $1.9M | 69k | 27.33 | |
| CHECK POINT SOFTWARE Technolog Com Stk (CHKP) | 0.4 | $1.8M | 27k | 67.63 | |
| Intra Cellular Therapies (ITCI) | 0.4 | $1.8M | 100k | 18.18 | |
| NCR Corporation (VYX) | 0.4 | $1.7M | 48k | 36.56 | |
| Summit Financial | 0.4 | $1.7M | 11M | 0.16 | |
| Five Prime Therapeutics | 0.4 | $1.8M | 90k | 19.66 | |
| Costco Wholesale Corporation (COST) | 0.4 | $1.7M | 15k | 111.69 | |
| Glycomimetics (GLYC) | 0.4 | $1.7M | 106k | 16.33 | |
| Flexion Therapeutics | 0.4 | $1.7M | 104k | 16.45 | |
| Ignyta | 0.4 | $1.7M | 205k | 8.30 | |
| Medivation Inc note 2.625% 4/0 | 0.4 | $1.6M | 25k | 64.36 | |
| Genvec | 0.3 | $1.5M | 575k | 2.65 | |
| Uniqure Nv (QURE) | 0.3 | $1.6M | 100k | 15.55 | |
| Ampio Pharmaceuticals | 0.3 | $1.4M | 225k | 6.35 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 0.3 | $1.4M | 20k | 70.70 | |
| Ironwood Pharmaceuticals (IRWD) | 0.3 | $1.4M | 113k | 12.32 | |
| Cytrx | 0.3 | $1.4M | 405k | 3.49 | |
| Relypsa | 0.3 | $1.4M | 47k | 29.81 | |
| Cell Therapeutics | 0.3 | $1.4M | 400k | 3.40 | |
| Tg Therapeutics (TGTX) | 0.3 | $1.4M | 200k | 6.90 | |
| Ambit Bioscience | 0.3 | $1.4M | 149k | 9.12 | |
| Insmed (INSM) | 0.3 | $1.3M | 70k | 19.04 | |
| Biolinerx Ltd-spons | 0.3 | $1.3M | 600k | 2.23 | |
| Bluebird Bio (BLUE) | 0.3 | $1.3M | 57k | 22.74 | |
| Immunomedics | 0.3 | $1.3M | 300k | 4.21 | |
| Ocera Therapeutics | 0.3 | $1.3M | 121k | 10.55 | |
| Tetrelogic Pharmaceuticals (TLOG) | 0.3 | $1.3M | 200k | 6.38 | |
| Dipexium Pharmaceuticals | 0.3 | $1.3M | 125k | 10.04 | |
| Alliance Data Systems Corporation (BFH) | 0.3 | $1.3M | 4.6k | 272.41 | |
| Nektar Therapeutics (NKTR) | 0.3 | $1.2M | 100k | 12.12 | |
| Peregrine Pharmaceuticals | 0.3 | $1.2M | 640k | 1.90 | |
| Curis | 0.3 | $1.2M | 439k | 2.82 | |
| Galectin Therapeutics Wrnt W Exp 3/28/2017 | 0.3 | $1.2M | 80k | 15.31 | |
| Cytokinetics (CYTK) | 0.3 | $1.2M | 130k | 9.50 | |
| Omeros Corporation (OMER) | 0.3 | $1.2M | 100k | 12.07 | |
| Xencor (XNCR) | 0.3 | $1.2M | 100k | 11.73 | |
| Gilead Sciences Inc option | 0.3 | $1.1M | 2.0k | 570.00 | |
| Macrogenics (MGNX) | 0.3 | $1.1M | 41k | 27.83 | |
| Qlt | 0.2 | $1.1M | 200k | 5.56 | |
| Stericycle (SRCL) | 0.2 | $1.1M | 9.4k | 113.57 | |
| Vanda Pharmaceuticals (VNDA) | 0.2 | $1.1M | 65k | 16.25 | |
| Discovery Laboratories | 0.2 | $1.1M | 500k | 2.15 | |
| Tonix Pharmaceuticls | 0.2 | $1.0M | 100k | 10.41 | |
| Ellomay Capital (ELLO) | 0.2 | $995k | 101k | 9.87 | |
| Kalobios Pharmaceuticals | 0.2 | $976k | 360k | 2.71 | |
| Glaxosmithkline | 0.2 | $878k | 3.0k | 292.67 | |
| Biodel | 0.2 | $775k | 284k | 2.73 | |
| Compugen Ltd ord | 0.2 | $726k | 69k | 10.51 | |
| Ormat Technologies (ORA) | 0.2 | $704k | 24k | 29.99 | |
| Ishares Tr Index option | 0.2 | $690k | 3.0k | 230.00 | |
| Acceleron Pharma | 0.2 | $690k | 20k | 34.50 | |
| F5 Networks (FFIV) | 0.1 | $663k | 6.2k | 106.56 | |
| Conatus Pharmaceuticals | 0.1 | $651k | 80k | 8.14 | |
| ImmunoGen | 0.1 | $515k | 35k | 14.93 | |
| Vertex Pharmaceuticals Inc option | 0.1 | $543k | 500.00 | 1086.00 | |
| Caesar Stone Sdot Yam (CSTE) | 0.1 | $426k | 7.8k | 54.41 | |
| Vical Incorporated | 0.1 | $387k | 300k | 1.29 | |
| Auxilium Pharmaceuticals Inc option | 0.1 | $332k | 935.00 | 355.08 | |
| Impax Laboratories Inc Cmn Stock cmn | 0.1 | $335k | 1.0k | 335.00 | |
| Insmed | 0.1 | $355k | 1.0k | 355.00 | |
| CORCEPT THERAPEUTICS INC COMMON Stock cmn | 0.0 | $124k | 1.2k | 102.82 | |
| Pfizer Inc option | 0.0 | $82k | 2.0k | 41.00 | |
| Cytokinetics | 0.0 | $16k | 131.00 | 122.14 |
